Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11311536 Amorphous solid dispersions

Overview Structured Data Issues Contributors Activity

All edits

Edits on 30 Oct, 2024

"update inverses"

edited on 30 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate

0

Edits on 23 Oct, 2024

"update inverses"

edited on 23 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12122792 Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders

0

Edits on 18 Sep, 2024

"update inverses"

edited on 18 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12090155 Methods

0

Edits on 28 Aug, 2024

"update inverses"

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12070459 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

0

Edits on 15 May, 2024

"update inverses"

edited on 15 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11980617 Methods of treating acute depression and/or acute anxiety

0

Edits on 17 Apr, 2024

"update inverses"

edited on 17 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11958852 Compounds and methods

0

Edits on 13 Sep, 2023

"update inverses"

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11753419 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders

Edits on 31 Mar, 2023

"update citations for inverse infoboxes"

edited on 31 Mar, 2023

Infobox

Patent Citations

US Patent 10363220 Compartmented pharmaceutical dosage forms

0

Edits on 28 Mar, 2023

"Entity importer update"

edited on 28 Mar, 2023

Infobox

Is a

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

113115360

Date of Patent

April 26, 2022

0

Patent Application Number

162211620

Date Filed

December 14, 2018

0

Patent Citations

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

0

US Patent 10363220 Compartmented pharmaceutical dosage forms

0

Patent Primary Examiner

Audrea B Coniglio

0

Edits on 24 Mar, 2023

"update citations for inverse infoboxes"

edited on 24 Mar, 2023

Infobox

Patent Citations

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

0

Edits on 26 Sep, 2022

"Entity importer update"

edited on 26 Sep, 2022

Infobox

Is a

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

113115360

Date of Patent

April 26, 2022

0

Patent Application Number

162211620

Date Filed

December 14, 2018

0

Patent Citations

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

0

US Patent 10363220 Compartmented pharmaceutical dosage forms

0

Patent Primary Examiner

Audrea B Coniglio

0

Edits on 26 Sep, 2022

"update citations for inverse infoboxes"

edited on 26 Sep, 2022

Infobox

Patent Citations

US Patent 10363220 Compartmented pharmaceutical dosage forms

0

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

edited on 25 Sep, 2022

Infobox

Patent Citations

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

0

Edits on 19 May, 2022

"Created via: Entity Importer"

created this topic on 19 May, 2022

Edits made to:

Infobox (+49 properties)

Article (+331 characters)

‌

US Patent 11311536 Amorphous solid dispersions

Article

The disclosure provides new, stable, pharmaceutically acceptable amorphous solid dispersions of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Infobox

Is a

Patent jurisdiction

United States Patent and Trademark Office

Patent number

11311536

Date of patent

April 26, 2022

Patent application number

16221162

Date Filed

December 14, 2018

Patent citations

US Patent 10258575 Oral drug dosage forms having desired drug release profiles and uses thereof

US Patent 10363220 Compartmented pharmaceutical dosage forms

Patent primary examiner

Audrea B Coniglio

Find more entities like US Patent 11311536 Amorphous solid dispersions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool